Evaluating a tool to improve confusion syndrome in elderly patients
Analysis of the Impact of a Temporo-spatial Reorientation Tool on the Speed of Improvement of Confusional Syndrome, Assessed by the 4 "A" Test, in Patients Aged Over 75 Years Hospitalized in the Medical and Health Care Department. Geriatric Rehabilitation.
This study is testing a new tool to see if it can help older patients with confusion feel better faster after being hospitalized.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 75 Years and up |
| Sex | All |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Trial ID | NCT06498297 on ClinicalTrials.gov |
What this trial studies
This observational study analyzes how a temporo-spatial reorientation tool affects the speed of improvement in patients suffering from confusional syndrome, particularly among the elderly. Confusional syndrome is characterized by attentional disorders and cognitive disorganization, which can be acute and reversible. The study aims to gather data from patients aged 75 and over who have been hospitalized and assessed for delirium using the 4AT tool. By examining the impact of this tool, the study seeks to identify effective strategies for managing and preventing confusion syndrome in vulnerable populations.
Who should consider this trial
Good fit: Ideal candidates for this study are hospitalized patients aged 75 and older who have been assessed for delirium.
Not a fit: Patients who do not meet the age requirement or have expressed opposition to the reuse of their data will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management and faster recovery from confusion syndrome in elderly patients.
How similar studies have performed: While the approach is focused on a specific tool for managing confusion syndrome, similar studies have shown promise in improving outcomes for patients with attentional disorders.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient aged 75 and over * Hospitalized at the HUS in the SMRG department during the period from January 1, 2021 to April 31, 2023 * Passed at least a 4AT during hospitalization * Absence of written opposition in the patient's medical file (and/or their legal representative if applicable) to the reuse of their data for scientific research purposes. Exclusion Criteria: \- Presence of written opposition from the patient (and/or their legal representative if applicable) in their medical file.
Where this trial is running
Strasbourg
- Service de Soins de Soins Médicaux et de Réadaptation - CHU de Strasbourg - France — Strasbourg, France (Recruiting)
Study contacts
- Study coordinator: Alexandre BOUSSUGE, MD
- Email: alexandre.boussuge@chru-strasbourg.fr
- Phone: 33 3 88 11 54 61
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.